Page last updated: 2024-10-17

citric acid, anhydrous and Neoplasms

citric acid, anhydrous has been researched along with Neoplasms in 94 studies

Citric Acid: A key intermediate in metabolism. It is an acid compound found in citrus fruits. The salts of citric acid (citrates) can be used as anticoagulants due to their calcium chelating ability.
citric acid : A tricarboxylic acid that is propane-1,2,3-tricarboxylic acid bearing a hydroxy substituent at position 2. It is an important metabolite in the pathway of all aerobic organisms.

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
" Evaluation of (1) age-related dietary trends over time and (2) factors involved in iron absorption leads to the hypothesis that the combination of citric acid and ascorbic acid (a synergistic pair of strong enhancers) is instrumental in causing a deleterious increase in iron load in aging populations."8.79Proposed role for a combination of citric acid and ascorbic acid in the production of dietary iron overload: a fundamental cause of disease. ( Crawford, RD, 1995)
" Evaluation of (1) age-related dietary trends over time and (2) factors involved in iron absorption leads to the hypothesis that the combination of citric acid and ascorbic acid (a synergistic pair of strong enhancers) is instrumental in causing a deleterious increase in iron load in aging populations."4.79Proposed role for a combination of citric acid and ascorbic acid in the production of dietary iron overload: a fundamental cause of disease. ( Crawford, RD, 1995)
" calcium gluconate for treatment of hypocalcemia."3.76Increased risk of citrate reactions in patients with multiple myeloma during peripheral blood stem cell leukapheresis. ( Adamski, J; Eisenmann, C; Griffin, AC; Milone, MC; Sachais, BS, 2010)
"The culmination of 80+ years of cancer research implicates the aberrant metabolism in tumor cells as a root cause of pathogenesis."2.82Citrate transporter inhibitors: possible new anticancer agents. ( Kaplan, RS; Mayor, JA; Patil, SA, 2022)
"It is well established that cancer cells acquire energy via the Warburg effect and oxidative phosphorylation."2.72Extracellular citrate and metabolic adaptations of cancer cells. ( Adamski, J; Flores-Borja, F; Gaumann, A; Mycielska, ME; Parkinson, EK; Zahn, G; Ziegler, C, 2021)
"Citrate plays a central role in cancer cells' metabolism and regulation."2.72Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update. ( Coquerel, A; Fournel, L; Fuks, D; Gligorov, J; Icard, P; Lincet, H; Simula, L; Wu, Z, 2021)
"An important feature shared by many cancer cells is drastically altered metabolism that is critical for rapid growth and proliferation."2.66Targeting citrate as a novel therapeutic strategy in cancer treatment. ( Huang, L; Peng, G; Wang, C; Xu, H, 2020)
"Metabolic reprogramming in cancer cells entails activities that involve several enzymes and metabolites to convert nutrient into building blocks that alter energy metabolism to fuel rapid cell division."2.66Cancer Cell Metabolites: Updates on Current Tracing Methods. ( Maniam, S, 2020)
"This cycle allows cancer cells to burn their host's lipid and protein reserves in order to sustain their own biosynthesis pathways."2.48Understanding the central role of citrate in the metabolism of cancer cells. ( Icard, P; Lincet, H; Poulain, L, 2012)
"Understanding the metabolism of cancer cells may help to develop new anti-cancer treatments."2.48A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells. ( Icard, P; Lincet, H, 2012)
"To restore effective apoptosis in tumors, we propose that the administration of citrate could inhibit ATP production, activate caspase-8 (a key necroptosis inhibitor), and downregulate key anti-apoptotic proteins (Bcl-xL and MCL1)."1.91The potential for citrate to reinforce epigenetic therapy by promoting apoptosis. ( Alifano, M; Icard, P; Simula, L, 2023)
"Berberine is an isoquinoline alkaloid extracted from the root, rhizome and stem bark of Coptidis Rhizoma."1.56Berberine inhibits cancer cells growth by suppressing fatty acid synthesis and biogenesis of extracellular vesicles. ( Gu, S; Huang, D; Li, Q; Liang, B; Ouyang, C; Song, X; Su, T; Xie, L; Xie, R; Xu, M; Xu, T, 2020)
"Immune surveillance of cancer cells is facilitated by the Natural Killer Group 2D (NKG2D) receptor expressed by different lymphocyte subsets."1.56Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells. ( Aldana, BI; Andresen, L; Bermejo, AV; Daskalaki, E; Desler, C; Gerhart-Hines, Z; Hansen, MH; Hiron, TK; Høgh, RI; Jepsen, SD; Lin, D; Madsen, M; Mellergaard, M; Møller, SH; O'Callaghan, CA; Rasmussen, LJ; Skov, S; Sustarsic, EG; Wandall, HH; Wheelock, CE, 2020)
"Depending on their immune status, solid tumors can be immunologically classified into three groups: "hot" tumors are infiltrated with T lymphocytes, "cold" tumors are not infiltrated and "immune excluded" tumors are only infiltrated in the peripheral tumor tissue."1.51Functionalization Of T Lymphocytes With Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles For Magnetically Controlled Immune Therapy. ( Alexiou, C; Band, J; Cebulla, N; Dudziak, D; Friedrich, B; Friedrich, RP; Janko, C; Lee, G; Mühlberger, M; Tietze, R; Unterweger, H, 2019)
"One hundred twenty two consecutive ICU cancer patients with AKI treated with citrate-based CVVHD were prospectively evaluated in this prospective observational study."1.48Use of regional citrate anticoagulation for continuous venovenous hemodialysis in critically ill cancer patients with acute kidney injury. ( Bezerra, JS; Burdmann, EA; Caires, RA; Costa E Silva, VT; Costalonga, EC; Fukushima, JT; Hajjar, LA; Oikawa, L; Oliveira Coelho, F; Oliveira, APL; Soares, CM, 2018)
" We also analysed the potential of these particles for magnetic fluid hyperthermia by determination of the specific absorption rate at a constant frequency of 215 kHz; the temperature increase of the particles was 30."1.39Cationic albumin-conjugated magnetite nanoparticles, novel candidate for hyperthermia cancer therapy. ( Cheraghipour, E; Javadpour, S, 2013)
"Furthermore, we demonstrate that cancer cells incubated with GNPs are killed when exposed to 13."1.37A radio-frequency coupling network for heating of citrate-coated gold nanoparticles for cancer therapy: design and analysis. ( Ferrara, KW; Ingham, ES; Kruse, DE; Lindfors, HA; Paoli, EE; Stephens, DN, 2011)
"Because AIDS patients frequently present with minimal symptomatology, radionuclide imaging with its ability to survey the entire body, is especially valuable."1.29The role of gallium and labeled leukocyte scintigraphy in the AIDS patient. ( Goldsmith, SJ; Palestro, CJ, 1995)
"Tumors were clearly visualized in 19 out of 32 sites, with 59% of positive rate."1.28[Tumor imaging using 99mTc-hexamethylpropyleneamine oxime]. ( Fujii, H; Hasegawa, T; Hashimoto, S; Hashimoto, T; Kinoshita, F; Kubo, A; Nakamura, K; Okuyama, Y; Sanmiya, T; Shimizu, S, 1990)
"All cases had malignant tumors."1.28[Study on liver uptake changes in serial 67Ga scintigraphy]. ( Kobayashi, H; Sakuma, S; Tanaka, K, 1989)

Research

Studies (94)

TimeframeStudies, this research(%)All Research%
pre-199024 (25.53)18.7374
1990's14 (14.89)18.2507
2000's7 (7.45)29.6817
2010's34 (36.17)24.3611
2020's15 (15.96)2.80

Authors

AuthorsStudies
Parkinson, EK1
Adamski, J2
Zahn, G1
Gaumann, A1
Flores-Borja, F1
Ziegler, C1
Mycielska, ME2
Patil, SA1
Mayor, JA1
Kaplan, RS1
Xia, Y2
Xue, H2
Li, J8
Yu, Y4
Huang, W1
Zhou, C2
Shi, T1
Cheng, Y1
Zhang, C4
Liu, S2
Song, Z1
Xu, S1
Lou, J1
van den Bosch, CH1
Loeffen, Y1
van der Steeg, AFW1
van der Bruggen, JT1
Frakking, FNJ1
Fiocco, M1
van de Ven, CP1
Wijnen, MHWA1
van de Wetering, MD1
Icard, P8
Alifano, M4
Simula, L3
Mühlberger, M1
Janko, C1
Unterweger, H1
Friedrich, RP1
Friedrich, B1
Band, J1
Cebulla, N1
Alexiou, C1
Dudziak, D1
Lee, G2
Tietze, R1
Huang, L3
Wang, C3
Xu, H3
Peng, G1
Ferraz, FS1
López, JL1
Lacerda, SMSN1
Procópio, MS1
Figueiredo, AFA1
Martins, EMN1
Guimarães, PPG1
Ladeira, LO1
Kitten, GT1
Dias, FF1
Domingues, RZ1
Costa, GMJ1
Halim, AA1
Alsayed, B1
Embarak, S1
Yaseen, T1
Dabbous, S1
Fontaine, O1
Dueluzeau, R1
Raibaud, P1
Chabanet, C1
Popoff, MR1
Badoual, J1
Gabilan, JC1
Andremont, A1
Gómez, L1
Andrés, S1
Sánchez, J1
Alonso, JM1
Rey, J1
López, F1
Jiménez, A1
Yan, Z1
Zhou, L1
Zhao, Y3
Wang, J6
Hu, K1
Liu, H4
Wang, H3
Guo, Z1
Song, Y1
Huang, H4
Yang, R1
Owen, TW1
Al-Kaysi, RO1
Bardeen, CJ1
Cheng, Q1
Wu, S1
Cheng, T2
Zhou, X1
Wang, B4
Zhang, Q4
Wu, X2
Yao, Y3
Ochiai, T1
Ishiguro, H2
Nakano, R2
Kubota, Y2
Hara, M1
Sunada, K1
Hashimoto, K1
Kajioka, J1
Fujishima, A1
Jiao, J3
Gai, QY3
Wang, W2
Zang, YP2
Niu, LL2
Fu, YJ3
Wang, X4
Yao, LP1
Qin, QP1
Wang, ZY1
Liu, J4
Aleksic Sabo, V1
Knezevic, P1
Borges-Argáez, R1
Chan-Balan, R1
Cetina-Montejo, L1
Ayora-Talavera, G1
Sansores-Peraza, P1
Gómez-Carballo, J1
Cáceres-Farfán, M1
Jang, J1
Akin, D1
Bashir, R1
Yu, Z1
Zhu, J2
Jiang, H1
He, C2
Xiao, Z1
Xu, J2
Sun, Q1
Han, D1
Lei, H1
Zhao, K2
Zhu, L1
Li, X4
Fu, H2
Wilson, BK1
Step, DL1
Maxwell, CL1
Gifford, CA1
Richards, CJ1
Krehbiel, CR1
Warner, JM1
Doerr, AJ1
Erickson, GE1
Guretzky, JA1
Rasby, RJ1
Watson, AK1
Klopfenstein, TJ1
Sun, Y4
Liu, Z3
Pham, TD1
Lee, BK1
Yang, FC1
Wu, KH1
Lin, WP1
Hu, MK1
Lin, L3
Shao, J1
Sun, M1
Xu, G1
Zhang, X6
Xu, N1
Wang, R1
He, H1
Dong, X2
Yang, M2
Yang, Q1
Duan, S1
Han, J2
Chen, L2
Yang, X1
Li, W3
Wang, T2
Campbell, DA1
Gao, K1
Zager, RA1
Johnson, ACM1
Guillem, A1
Keyser, J1
Singh, B1
Steubl, D1
Schneider, MP1
Meiselbach, H1
Nadal, J1
Schmid, MC1
Saritas, T1
Krane, V1
Sommerer, C1
Baid-Agrawal, S1
Voelkl, J1
Kotsis, F1
Köttgen, A1
Eckardt, KU1
Scherberich, JE1
Li, H4
Yao, L2
Sun, L3
Zhu, Z1
Naren, N1
Zhang, XX2
Gentile, GL1
Rupert, AS1
Carrasco, LI1
Garcia, EM1
Kumar, NG1
Walsh, SW1
Jefferson, KK1
Guest, RL1
Samé Guerra, D1
Wissler, M1
Grimm, J1
Silhavy, TJ1
Lee, JH2
Yoo, JS1
Kim, Y1
Kim, JS2
Lee, EJ1
Roe, JH1
Delorme, M1
Bouchard, PA1
Simon, M1
Simard, S1
Lellouche, F1
D'Urzo, KA1
Mok, F1
D'Urzo, AD1
Koneru, B1
Lopez, G1
Farooqi, A1
Conkrite, KL1
Nguyen, TH1
Macha, SJ1
Modi, A1
Rokita, JL1
Urias, E1
Hindle, A1
Davidson, H1
Mccoy, K1
Nance, J1
Yazdani, V1
Irwin, MS1
Yang, S1
Wheeler, DA1
Maris, JM1
Diskin, SJ1
Reynolds, CP1
Abhilash, L1
Kalliyil, A1
Sheeba, V1
Hartley, AM2
Meunier, B2
Pinotsis, N1
Maréchal, A2
Xu, JY1
Genko, N1
Haraux, F1
Rich, PR1
Kamalanathan, M1
Doyle, SM1
Xu, C1
Achberger, AM1
Wade, TL1
Schwehr, K1
Santschi, PH1
Sylvan, JB1
Quigg, A1
Leong, W1
Xu, W2
Gao, S1
Zhai, X1
Gilson, E1
Ye, J1
Lu, Y1
Yan, R1
Zhang, Y6
Hu, Z1
You, Q1
Cai, Q1
Yang, D1
Gu, S2
Dai, H1
Zhao, X1
Gui, C1
Gui, J1
Wu, PK1
Hong, SK1
Starenki, D1
Oshima, K1
Shao, H1
Gestwicki, JE1
Tsai, S1
Park, JI1
Wang, Y7
Zhao, R1
Gu, Z1
Dong, C2
Guo, G1
Li, L4
Barrett, HE1
Meester, EJ1
van Gaalen, K1
van der Heiden, K1
Krenning, BJ1
Beekman, FJ1
de Blois, E1
de Swart, J1
Verhagen, HJ1
Maina, T1
Nock, BA1
Norenberg, JP1
de Jong, M1
Gijsen, FJH1
Bernsen, MR1
Martínez-Milla, J1
Galán-Arriola, C1
Carnero, M1
Cobiella, J1
Pérez-Camargo, D1
Bautista-Hernández, V1
Rigol, M1
Solanes, N1
Villena-Gutierrez, R1
Lobo, M1
Mateo, J1
Vilchez-Tschischke, JP1
Salinas, B1
Cussó, L1
López, GJ1
Fuster, V1
Desco, M1
Sanchez-González, J1
Ibanez, B1
van den Berg, P1
Schweitzer, DH1
van Haard, PMM1
Geusens, PP1
van den Bergh, JP1
Zhu, X1
Huang, X2
Yang, G2
Lin, Z1
Salem, HF1
Nafady, MM1
Kharshoum, RM1
Abd El-Ghafar, OA1
Farouk, HO1
Domiciano, D1
Nery, FC1
de Carvalho, PA1
Prudente, DO1
de Souza, LB1
Chalfun-Júnior, A1
Paiva, R1
Marchiori, PER1
Lu, M2
An, Z1
Jiang, J2
Du, S1
Zhou, H1
Cui, J1
Wu, W1
Liu, Y7
Song, J1
Lian, Q1
Uddin Ahmad, Z1
Gang, DD1
Konggidinata, MI1
Gallo, AA1
Zappi, ME1
Yang, TWW1
Johari, Y1
Burton, PR1
Earnest, A1
Shaw, K1
Hare, JL1
Brown, WA1
Kim, GA1
Han, S1
Choi, GH1
Choi, J1
Lim, YS1
Gallo, A1
Cancelli, C1
Ceron, E1
Covino, M1
Capoluongo, E1
Pocino, K1
Ianiro, G1
Cammarota, G1
Gasbarrini, A1
Montalto, M1
Somasundar, Y1
Lu, IC1
Mills, MR1
Qian, LY1
Olivares, X1
Ryabov, AD1
Collins, TJ1
Zhao, L1
Doddipatla, S1
Thomas, AM1
Nikolayev, AA1
Galimova, GR1
Azyazov, VN1
Mebel, AM1
Kaiser, RI1
Guo, S1
Yang, P1
Yu, X2
Wu, Y2
Zhang, H1
Yu, B2
Han, B1
George, MW1
Moor, MB1
Bonny, O1
Langenberg, E1
Paik, H1
Smith, EH1
Nair, HP1
Hanke, I1
Ganschow, S1
Catalan, G1
Domingo, N1
Schlom, DG1
Assefa, MK1
Wu, G2
Hayton, TW1
Becker, B1
Enikeev, D1
Netsch, C1
Gross, AJ1
Laukhtina, E1
Glybochko, P1
Rapoport, L1
Herrmann, TRW1
Taratkin, M1
Dai, W1
Shi, J2
Carreno, J1
Kloner, RA1
Pickersgill, NA1
Vetter, JM1
Kim, EH1
Cope, SJ1
Du, K1
Venkatesh, R1
Giardina, JD1
Saad, NES1
Bhayani, SB1
Figenshau, RS1
Eriksson, J1
Landfeldt, E1
Ireland, S1
Jackson, C1
Wyatt, E1
Gaudig, M1
Stancill, JS1
Happ, JT1
Broniowska, KA1
Hogg, N1
Corbett, JA1
Tang, LF1
Bi, YL1
Fan, Y2
Sun, YB1
Wang, AL1
Xiao, BH1
Wang, LF1
Qiu, SW1
Guo, SW1
Wáng, YXJ1
Sun, J2
Chu, S1
Pan, Q1
Li, D2
Zheng, S2
Ma, L1
Wang, L3
Hu, T1
Wang, F1
Han, Z1
Yin, Z1
Ge, X1
Xie, K1
Lei, P1
Dias-Santagata, D1
Lennerz, JK1
Sadow, PM1
Frazier, RP1
Govinda Raju, S1
Henry, D1
Chung, T1
Kherani, J1
Rothenberg, SM1
Wirth, LJ1
Marti, CN1
Choi, NG1
Bae, SJ1
Ni, L1
Luo, X1
Dai, T1
Yang, Y4
Lee, R1
Fleischer, AS1
Wemhoff, AP1
Ford, CR1
Kleppinger, EL1
Helms, K1
Bush, AA1
Luna-Abanto, J1
García Ruiz, L1
Laura Martinez, J1
Álvarez Larraondo, M1
Villoslada Terrones, V1
Dukic, L1
Maric, N1
Simundic, AM1
Chogtu, B1
Ommurugan, B1
Thomson, SR1
Kalthur, SG1
Benidir, M1
El Massoudi, S1
El Ghadraoui, L1
Lazraq, A1
Benjelloun, M1
Errachidi, F1
Cassar, M1
Law, AD1
Chow, ES1
Giebultowicz, JM1
Kretzschmar, D1
Salonurmi, T1
Nabil, H1
Ronkainen, J1
Hyötyläinen, T1
Hautajärvi, H1
Savolainen, MJ1
Tolonen, A1
Orešič, M1
Känsäkoski, P1
Rysä, J1
Hakkola, J1
Hukkanen, J1
Zhu, N1
Li, Y4
Du, Q1
Hao, P1
Cao, X1
Li, CX1
Zhao, S1
Luo, XM1
Feng, JX1
Gonzalez-Cotto, M1
Guo, L1
Karwan, M1
Sen, SK1
Barb, J1
Collado, CJ1
Elloumi, F1
Palmieri, EM1
Boelte, K1
Kolodgie, FD1
Finn, AV1
Biesecker, LG1
McVicar, DW1
Qu, F1
Deng, Z1
Xie, Y2
Tang, J3
Chen, Z2
Luo, W1
Xiong, D1
Zhao, D1
Fang, J1
Zhou, Z1
Niu, PP1
Song, B1
Xu, YM1
Zhang, Z2
Qiu, N1
Yin, J1
Zhang, J3
Guo, W1
Liu, M2
Liu, T2
Chen, D5
Luo, K1
He, Z2
Zheng, G1
Xu, F1
Sun, W1
Yin, F1
van Hest, JCM1
Du, L2
Shi, X1
Kang, S1
Duan, W1
Zhang, S2
Feng, J2
Qi, N1
Shen, G1
Ren, H1
Shang, Q1
Zhao, W2
Yang, Z2
Jiang, X2
Alame, M1
Cornillot, E1
Cacheux, V1
Tosato, G1
Four, M1
De Oliveira, L1
Gofflot, S1
Delvenne, P1
Turtoi, E1
Cabello-Aguilar, S1
Nishiyama, M1
Turtoi, A1
Costes-Martineau, V1
Colinge, J1
Guo, Q1
Quan, M1
Dong, J1
Bai, J1
Han, R1
Cai, Y1
Lv, YQ1
Chen, Q1
Lyu, HD1
Deng, L1
Zhou, D1
Xiao, X1
De Langhe, S1
Billadeau, DD1
Lou, Z1
Zhang, JS1
Xue, Z1
Shen, XD1
Gao, F1
Busuttil, RW1
Kupiec-Weglinski, JW1
Ji, H1
Otano, I1
Alvarez, M1
Minute, L1
Ochoa, MC1
Migueliz, I1
Molina, C1
Azpilikueta, A1
de Andrea, CE1
Etxeberria, I1
Sanmamed, MF1
Teijeira, Á1
Berraondo, P1
Melero, I1
Zhong, Z1
Xie, X1
Yu, Q1
Liu, C2
Liu, W1
Chen, W1
Yin, Y1
Li, CW1
Hsu, JL1
Zhou, Q1
Hu, B1
Fu, P1
Atyah, M1
Ma, Q2
Xu, Y1
Dong, Q1
Hung, MC1
Ren, N1
Huang, P1
Liao, R1
Chen, X3
Cao, Q1
Yuan, X1
Nie, W1
Yang, J2
Shao, B1
Ma, X1
Bi, Z1
Liang, X1
Tie, Y1
Mo, F1
Xie, D1
Wei, Y1
Wei, X2
Dokla, EME1
Fang, CS1
Chu, PC1
Chang, CS1
Abouzid, KAM1
Chen, CS1
Blaszczyk, R1
Brzezinska, J1
Dymek, B1
Stanczak, PS1
Mazurkiewicz, M1
Olczak, J1
Nowicka, J1
Dzwonek, K1
Zagozdzon, A1
Golab, J1
Golebiowski, A1
Xin, Z1
Himmelbauer, MK1
Jones, JH1
Enyedy, I1
Gilfillan, R1
Hesson, T1
King, K1
Marcotte, DJ1
Murugan, P1
Santoro, JC1
Gonzalez-Lopez de Turiso, F1
Pedron, J1
Boudot, C1
Brossas, JY1
Pinault, E1
Bourgeade-Delmas, S1
Sournia-Saquet, A1
Boutet-Robinet, E1
Destere, A1
Tronnet, A1
Bergé, J1
Bonduelle, C1
Deraeve, C1
Pratviel, G1
Stigliani, JL1
Paris, L1
Mazier, D1
Corvaisier, S1
Since, M1
Malzert-Fréon, A1
Wyllie, S1
Milne, R1
Fairlamb, AH1
Valentin, A1
Courtioux, B1
Verhaeghe, P1
Fang, X1
Gao, M1
Gao, H1
Bi, W1
Tang, H1
Cui, Y1
Zhang, L3
Fan, H1
Yu, H1
Mathison, CJN1
Chianelli, D1
Rucker, PV1
Nelson, J1
Roland, J1
Huang, Z2
Xie, YF1
Epple, R1
Bursulaya, B1
Lee, C1
Gao, MY1
Shaffer, J1
Briones, S1
Sarkisova, Y1
Galkin, A1
Li, N1
Li, C2
Hua, S1
Kasibhatla, S1
Kinyamu-Akunda, J1
Kikkawa, R1
Molteni, V1
Tellew, JE1
Jin, X1
Pang, B1
Liu, Q2
Liu, X3
Huang, Y2
Josephine Fauci, A1
Ma, Y1
Soo Lee, M1
Yuan, W1
Gao, R1
Qi, H1
Zheng, W1
Yang, F2
Chua, H1
Wang, K1
Ou, Y1
Huang, M1
Zhu, Y1
Yu, J1
Tian, J1
Zhao, M1
Hu, J1
Yao, C1
Zhang, B1
Usawachintachit, M1
Tzou, DT1
Washington, SL1
Hu, W1
Chi, T1
Sorensen, MD1
Bailey, MR1
Hsi, RS1
Cunitz, BW1
Simon, J1
Wang, YN1
Dunmire, BL1
Paun, M1
Starr, F1
Lu, W1
Evan, AP1
Harper, JD1
Han, G1
Rodrigues, AE1
Fouladvand, F1
Falahi, E1
Asbaghi, O1
Abbasnezhad, A1
Anigboro, AA1
Avwioroko, OJ1
Cholu, CO1
Sonei, A1
Fazelipour, S1
Kanaani, L1
Jahromy, MH1
Jo, K1
Hong, KB1
Suh, HJ1
Park, JH1
Shin, E1
Park, E1
Kouakou-Kouamé, CA1
N'guessan, FK1
Montet, D1
Djè, MK1
Kim, GD1
González-Fernández, D1
Pons, EDC1
Rueda, D1
Sinisterra, OT1
Murillo, E1
Scott, ME1
Koski, KG1
Shete, PB1
Gonzales, R1
Ackerman, S1
Cattamanchi, A1
Handley, MA1
Li, XX1
Xiao, SZ1
Gu, FF1
He, WP1
Ni, YX1
Han, LZ1
Heffernan, JK1
Valgepea, K1
de Souza Pinto Lemgruber, R1
Casini, I1
Plan, M1
Tappel, R1
Simpson, SD1
Köpke, M1
Nielsen, LK1
Marcellin, E1
Cen, YK1
Lin, JG1
Wang, YL1
Wang, JY1
Liu, ZQ1
Zheng, YG1
Spirk, D1
Noll, S1
Burnier, M1
Rimoldi, S1
Noll, G1
Sudano, I1
Penzhorn, BL1
Oosthuizen, MC1
Kobos, LM1
Alqatani, S1
Ferreira, CR1
Aryal, UK1
Hedrick, V1
Sobreira, TJP1
Shannahan, JH1
Gale, P1
Singhroy, DN1
MacLean, E1
Kohli, M1
Lessem, E1
Branigan, D1
England, K1
Suleiman, K1
Drain, PK1
Ruhwald, M1
Schumacher, S1
Denkinger, CM1
Waning, B1
Van Gemert, W1
Pai, M1
Myers, RK1
Bonsu, JM1
Carey, ME1
Yerys, BE1
Mollen, CJ1
Curry, AE1
Douglas, TA1
Alinezhadbalalami, N1
Balani, N1
Schmelz, EM1
Davalos, RV1
Kamaldinov, T1
Erndt-Marino, J1
Levin, M1
Kaplan, DL1
Hahn, MS1
Heidarimoghadam, R1
Farmany, A1
Lee, JJ1
Kang, J1
Park, S1
Cho, JH1
Oh, S1
Park, DJ1
Perez-Maldonado, R1
Cho, JY1
Park, IH1
Kim, HB1
Song, M1
Mfarrej, B1
Jofra, T1
Morsiani, C1
Gagliani, N1
Fousteri, G1
Battaglia, M1
Giuliano, C1
Levinger, I1
Vogrin, S1
Neil, CJ1
Allen, JD1
Lv, Y1
Yuan, R1
Cai, B1
Bahrami, B1
Chowdhury, AH1
Yang, C3
Qiao, Q1
Liu, SF1
Zhang, WH1
Kolano, L1
Knappe, D1
Volke, D1
Sträter, N1
Hoffmann, R1
Coussens, M1
Calders, P1
Lapauw, B1
Celie, B1
Banica, T1
De Wandele, I1
Pacey, V1
Malfait, F1
Rombaut, L1
Vieira, D1
Angel, S1
Honjol, Y1
Gruenheid, S1
Gbureck, U1
Harvey, E1
Merle, G1
Seo, G1
Kim, MJ1
Baek, SH1
Choi, M1
Ku, KB1
Lee, CS1
Jun, S1
Park, D1
Kim, HG1
Kim, SJ1
Lee, JO1
Kim, BT1
Park, EC1
Kim, SI1
Ende, M1
Kirkkala, T1
Loitzenbauer, M1
Talla, D1
Wildner, M1
Miletich, R1
Criado, A1
Lavela, P1
Tirado, JL1
Pérez-Vicente, C1
Kang, D1
Feng, D2
Fang, Z1
Wei, F1
De Clercq, E1
Pannecouque, C1
Zhan, P1
Guo, Y2
Shen, Y1
Wang, Q2
Kawazoe, Y1
Jena, P1
Sun, Z1
Li, Z2
Liang, H1
Xu, X1
Ma, G1
Huo, X1
Church, JS1
Chace-Donahue, F1
Blum, JL1
Ratner, JR1
Zelikoff, JT1
Schwartzer, JJ1
Fiseha, T1
Tamir, Z1
Yao, W1
Wang, P1
Mi, K1
Cheng, J1
Gu, C1
Huang, J2
Sun, HB1
Xing, WQ1
Liu, XB1
Zheng, Y1
Yang, SJ1
Wang, ZF1
Liu, SL1
Ba, YF1
Zhang, RX1
Liu, BX1
Fan, CC1
Chen, PN1
Liang, GH1
Yu, YK1
Wang, HR1
Li, HM1
Li, ZX1
Lalani, SS1
Anasir, MI1
Poh, CL1
Khan, IT1
Nadeem, M1
Imran, M1
Khalique, A1
Raspini, B1
Porri, D1
De Giuseppe, R1
Chieppa, M1
Liso, M1
Cerbo, RM1
Civardi, E1
Garofoli, F1
Monti, MC1
Vacca, M1
De Angelis, M1
Cena, H1
Kong, D1
Han, X1
Zhou, Y3
Zhang, W1
Ruan, Z1
Li, S2
Noer, PR1
Kjaer-Sorensen, K1
Juhl, AK1
Goldstein, A1
Ke, C1
Oxvig, C1
Duan, C1
Kong, F1
Lin, S1
Wang, Z2
Bhattacharya, R1
Mazumder, D1
Yan, X1
Ma, C1
Tang, Y1
Kong, X1
Lu, J1
Zhang, M1
Vital-Jacome, M1
Cazares-Granillo, M1
Carrillo-Reyes, J1
Buitron, G1
Jacob, SI1
Douair, I1
Maron, L1
Ménard, G1
Rusjan, P1
Sabioni, P1
Di Ciano, P1
Mansouri, E1
Boileau, I1
Laveillé, A1
Capet, M1
Duvauchelle, T1
Schwartz, JC1
Robert, P1
Le Foll, B1
Chen, S1
Luo, M1
Wu, J1
Cai, S1
He, Y2
Garbacz, P1
Misiak, M1
Jackowski, K1
Yuan, Q1
Sherrell, PC1
Chen, J2
Bi, X1
Nutho, B1
Mahalapbutr, P1
Hengphasatporn, K1
Pattaranggoon, NC1
Simanon, N1
Shigeta, Y1
Hannongbua, S1
Rungrotmongkol, T1
Caffrey, PJ1
Kher, R1
Bian, K1
Delaney, S1
Xue, J1
Wu, P1
Xu, L1
Yuan, Y1
Luo, J1
Ye, S1
Ustriyana, P1
Wei, B1
Raee, E1
Hu, Y1
Wesdemiotis, C1
Sahai, N1
Kaur, A1
Nigam, K1
Srivastava, S1
Tyagi, A1
Dang, S1
Millar, JE1
Bartnikowski, N1
Passmore, MR1
Obonyo, NG1
Malfertheiner, MV1
von Bahr, V1
Redd, MA1
See Hoe, L1
Ki, KK1
Pedersen, S1
Boyle, AJ1
Baillie, JK1
Shekar, K1
Palpant, N1
Suen, JY1
Matthay, MA1
McAuley, DF1
Fraser, JF1
Settles, JA1
Gerety, GF1
Spaepen, E1
Suico, JG1
Child, CJ1
Oh, BL1
Lee, JS1
Lee, EY1
Lee, HY1
Yu, HG1
Leslie, I1
Boos, LA1
Larkin, J1
Pickering, L1
Lima, HK1
Vogel, K1
Hampel, D1
Wagner-Gillespie, M1
Fogleman, AD1
Ferraz, SL1
O'Connor, M1
Mazzucchelli, TG1
Kajiyama, H1
Suzuki, S1
Shimbo, A1
Utsumi, F1
Yoshikawa, N1
Kikkawa, F1
Javvaji, PK1
Dhali, A1
Francis, JR1
Kolte, AP1
Roy, SC1
Selvaraju, S1
Mech, A1
Sejian, V1
DeSilva, S1
Vaidya, SS1
Mao, C1
Akhatayeva, Z1
Cheng, H1
Zhang, G1
Jiang, F1
Meng, X1
Elnour, IE1
Lan, X1
Song, E1
Rohde, S1
Antonides, CFJ1
Muslem, R1
de Woestijne, PCV1
der Meulen, MHV1
Kraemer, US1
Dalinghaus, M1
Bogers, AJJC1
Pourmand, A1
Ghassemi, M1
Sumon, K1
Amini, SB1
Hood, C1
Sikka, N1
Duan, H1
Chen, WP1
Fan, M1
Wang, WP1
Yu, L1
Tan, SJ1
Xin, S1
Wan, LJ1
Guo, YG1
Tanda, S1
Gingl, K1
Ličbinský, R1
Hegrová, J1
Goessler, W1
Li, ZL1
Zhou, YL1
Yan, W1
Luo, L1
Su, ZZ1
Fan, MZ1
Wang, SR1
Zhao, WG1
Xu, D1
Hassan, HM1
Jiang, Z1
Bachmann, KF1
Haenggi, M1
Jakob, SM1
Takala, J1
Gattinoni, L1
Berger, D1
Bentley, RF1
Vecchiarelli, E1
Banks, L1
Gonçalves, PEO1
Thomas, SG1
Goodman, JM1
Mather, K1
Boachie, R1
Anini, Y1
Panahi, S1
Anderson, GH1
Luhovyy, BL1
Nafie, MS1
Arafa, K1
Sedky, NK1
Alakhdar, AA1
Arafa, RK1
Fan, S1
Hu, H1
Liang, J1
Hu, BC1
Wen, Z1
Hu, D1
Liu, YY1
Chu, Q1
Wu, MC1
Lu, X1
Wang, D1
Hu, M1
Shen, H1
Yao, M1
Dahlgren, RA1
Vysloužil, J1
Kulich, P1
Zeman, T1
Vaculovič, T1
Tvrdoňová, M1
Mikuška, P1
Večeřa, Z1
Stráská, J1
Moravec, P1
Balcar, VJ1
Šerý, O1
Qiao, L1
Xiong, X1
Peng, X1
Zheng, J1
Duan, J1
Xiao, W1
Zhou, HY1
Sui, ZY1
Zhao, FL1
Sun, YN1
Wang, HY1
Han, BH1
Jintao, X1
Shasha, Y1
Jincai, W1
Chunyan, L1
Mengya, Y1
Yongli, S1
Rasoanirina, BNV1
Lassoued, MA1
Miladi, K1
Razafindrakoto, Z1
Chaâbane-Banaoues, R1
Ramanitrahasimbola, D1
Cornet, M1
Sfar, S1
Liang, C1
Xing, Q1
Yi, JL1
Zhang, YQ1
Li, CY1
Tang, SJ1
Gao, C1
Sun, X1
Peng, M1
Sun, XF1
Zhang, T1
Shi, JH1
Liao, CX1
Gao, WJ1
Sun, LL1
Gao, Y1
Cao, WH1
Lyu, J1
Yu, CQ1
Wang, SF1
Pang, ZC1
Cong, LM1
Dong, Z1
Wu, F1
Wu, XP1
Jiang, GH1
Wang, XJ1
Wang, BY1
Li, LM1
Pan, L1
Wan, SP1
Yi, HWL1
He, HJ1
Yong, ZP1
Shan, GL1
Weng, TT1
Yan, SQ1
Gao, GP1
Wei, C1
Tao, FB1
Shao, ZH1
Yao, T1
Dong, S1
Shi, S1
Feng, YL1
Zhang, YW1
Wang, SP1
Shi, AX1
Operario, D1
Zhang, ZH1
Zhu, XF1
Zaller, N1
Gao, P1
Sun, YH1
Zhang, HB1
Maniam, S2
Song, X1
Xie, R1
Ouyang, C1
Xie, L1
Li, Q1
Su, T1
Xu, M1
Xu, T1
Huang, D1
Liang, B1
Møller, SH1
Mellergaard, M1
Madsen, M1
Bermejo, AV1
Jepsen, SD1
Hansen, MH1
Høgh, RI1
Aldana, BI1
Desler, C1
Rasmussen, LJ1
Sustarsic, EG1
Gerhart-Hines, Z1
Daskalaki, E1
Wheelock, CE1
Hiron, TK1
Lin, D1
O'Callaghan, CA1
Wandall, HH1
Andresen, L1
Skov, S1
Wang, M2
Chen, M2
Niu, W2
Winston, DD1
Cheng, W1
Lei, B2
Mosaoa, R1
Kasprzyk-Pawelec, A1
Fernandez, HR1
Avantaggiati, ML1
Kopel, JJ1
Bhutia, YD1
Sivaprakasam, S1
Ganapathy, V1
Donnadieu, E1
Coquerel, A1
Wu, Z2
Gligorov, J1
Fuks, D1
Fournel, L3
Lincet, H6
Saw, WS1
Ujihara, M1
Chong, WY1
Voon, SH1
Imae, T1
Kiew, LV1
Lee, HB1
Sim, KS1
Chung, LY1
Costa E Silva, VT1
Caires, RA1
Bezerra, JS1
Costalonga, EC1
Oliveira, APL1
Oliveira Coelho, F1
Fukushima, JT1
Soares, CM1
Oikawa, L1
Hajjar, LA1
Burdmann, EA1
Geissler, EK1
Pathak, PK1
Kumar, A1
Prasad, BB1
Xue, Y1
Ma, PX1
Khodaei, R1
Ahmady, A1
Khoshfetrat, SM1
Kashanian, S1
Tavangar, SM1
Omidfar, K1
Lee, WD1
Mukha, D1
Aizenshtein, E1
Shlomi, T1
Maj, C1
Mosca, E1
Merelli, I1
Mauri, G1
Milanesi, L1
Halabe Bucay, A1
Chiang, WH1
Ho, VT1
Chen, HH1
Huang, WC1
Huang, YF1
Lin, SC1
Chern, CS1
Chiu, HC1
Cheraghipour, E1
Javadpour, S1
Palsson-McDermott, EM1
O'Neill, LA1
Rodrigues, HF1
Mello, FM1
Branquinho, LC1
Zufelato, N1
Silveira-Lacerda, EP1
Bakuzis, AF1
Iacobazzi, V1
Infantino, V1
Crecelius, AC1
Schubert, US1
von Eggeling, F1
Jiang, L1
Shestov, AA1
Swain, P1
Parker, SJ1
Wang, QA1
Terada, LS1
Adams, ND1
McCabe, MT1
Pietrak, B1
Schmidt, S1
Metallo, CM1
Dranka, BP1
Schwartz, B1
DeBerardinis, RJ2
Khaleghi, S1
Rahbarizadeh, F1
Ahmadvand, D1
Malek, M1
Madaah Hosseini, HR1
Griffin, AC1
Eisenmann, C1
Milone, MC1
Sachais, BS1
Kruse, DE1
Stephens, DN1
Lindfors, HA1
Ingham, ES1
Paoli, EE1
Ferrara, KW1
Raji, V1
Kumar, J1
Rejiya, CS1
Vibin, M1
Shenoi, VN1
Abraham, A1
Clippinger, AJ1
Alwine, JC1
Sassi, M1
Dell'Anna, P1
Bernuzzi, G1
Adorni, D1
Fagnoni, F1
Cepparulo, A1
Eterno, A1
Barilli, M1
Ampollini, M1
Formentini, A1
Franchini, M1
Poulain, L1
Mullen, AR1
Wheaton, WW1
Jin, ES1
Chen, PH1
Sullivan, LB1
Linehan, WM1
Chandel, NS1
Agarwal, N1
Zu, XY1
Zhang, QH1
Liu, JH1
Cao, RX1
Zhong, J1
Yi, GH1
Quan, ZH1
Pizzorno, G1
Takakuwa, O1
Oguri, T1
Maeno, K1
Yokoyama, M1
Hijikata, H1
Uemura, T1
Ozasa, H1
Ohkubo, H1
Miyazaki, M1
Niimi, A1
Johnson, S1
BRYAN, WR3
LORENZ, E1
CALNAN, D2
BUSCH, H2
DAVIS, JR1
OLLE, EW1
RECHENBERGER, J1
BENNDORF, S1
PISARZEWSKI, A1
TAUFEL, K1
GRAFFI, A1
ZANDER-PRINCIPATI, GE3
KUZMA, JF3
LUTWAK-MANN, C2
BEHNKE, U1
KETZ, HA1
TAEUFEL, K1
HOFFMANN, F1
COOPER, JF1
FARID, I1
FOCHEM, K1
SPURNY, J1
MARBERGER, H1
MARBERGER, E1
MANN, T1
REISS, OK1
HELLERMAN, L1
AMBROS, JA1
SMITH, CI1
GEY, MK1
IBER, AE1
Chin, SF1
Daigo, Y1
Huang, HE1
Iyer, NG1
Callagy, G1
Kranjac, T1
Gonzalez, M1
Sangan, T1
Earl, H1
Caldas, C1
MILLER, H1
CARRUTHERS, C1
MAVER, ME2
MOLONEY, JB2
WOOD, MT2
WHITE, CL2
Sevilla, J1
González-Vicent, M1
Fernández-Plaza, S1
Madero, L1
Díaz, MA1
POTTER, VR1
Gillies, RJ1
Morse, DL1
Costello, LC1
Franklin, RB1
Brière, JJ1
Favier, J1
Gimenez-Roqueplo, AP1
Rustin, P1
HAVEN, FL1
RANDALL, C1
BLOOR, WR1
Crawford, RD1
Palestro, CJ1
Goldsmith, SJ1
Larson, SM1
Voest, EE1
Neijt, JP1
Keunen, JE1
Dekker, AW1
van Asbeck, BS1
Nortier, JW1
Ros, FE1
Marx, JJ1
Smith, AG1
Jackson, GE1
Byrne, MJ1
Board, M1
Newsholme, E1
Uno, K2
Kuyama, J1
Uchida, Y1
Sakata, S1
Kitakata, Y1
Zalit, I1
Glass, GA1
Stark, AA1
Ratcliffe, N1
Blume, C1
John, P1
Weiss, T1
Hubbell, C1
Henry, JB1
Hammoud, M1
Van Noorden, S1
Landolfo, A1
Angioni, A1
Deb, G1
Jenkner, A1
Orlando, P1
Donfrancesco, A1
Balloni, P1
Boschman, GA1
Rens, W1
van Oven, CH1
Manders, EM1
Aten, JA1
Rossleigh, MA1
Murray, IP1
Mackey, DW1
Bargwanna, KA1
Nayanar, VV1
Fujii, H1
Hashimoto, T1
Nakamura, K1
Sanmiya, T1
Shimizu, S1
Okuyama, Y1
Hasegawa, T1
Kubo, A1
Kinoshita, F1
Hashimoto, S1
Ohnishi, T1
Jinnouchi, S1
Hoshi, H1
Yoshimura, H1
Nagamachi, S1
Watanabe, K1
Kobayashi, H1
Tanaka, K1
Sakuma, S1
Minoshima, S1
Anzai, Y1
Okada, J1
Yoshikawa, K1
Arimizu, N1
Hisada, K1
Tonami, N1
Michigishi, T1
Yokoyama, K1
Prichodko, AG1
Rozdilski, SI1
Sorokin, IN1
Duma, VA1
Pylev, LN1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Single-arm Phase II Clinical Trial to Evaluate the Initial Efficacy and Safety of Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma[NCT04387500]Phase 241 participants (Anticipated)Interventional2021-07-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

23 reviews available for citric acid, anhydrous and Neoplasms

ArticleYear
Extracellular citrate and metabolic adaptations of cancer cells.
    Cancer metastasis reviews, 2021, Volume: 40, Issue:4

    Topics: Citrates; Citric Acid; Citric Acid Cycle; Humans; Neoplasms; Oxidative Phosphorylation; Tumor Microe

2021
Citrate transporter inhibitors: possible new anticancer agents.
    Future medicinal chemistry, 2022, Volume: 14, Issue:9

    Topics: Antineoplastic Agents; Carrier Proteins; Citric Acid; Humans; Neoplasms

2022
Targeting citrate as a novel therapeutic strategy in cancer treatment.
    Biochimica et biophysica acta. Reviews on cancer, 2020, Volume: 1873, Issue:1

    Topics: Apoptosis; Cell Proliferation; Citrate (si)-Synthase; Citric Acid; Energy Metabolism; Humans; Metabo

2020
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Cancer Cell Metabolites: Updates on Current Tracing Methods.
    Chembiochem : a European journal of chemical biology, 2020, 12-11, Volume: 21, Issue:24

    Topics: Amino Acids; Citric Acid; Glucose; Glycine; Humans; Isotope Labeling; Lactic Acid; Neoplasms; Succin

2020
The Mitochondrial Citrate Carrier SLC25A1/CIC and the Fundamental Role of Citrate in Cancer, Inflammation and Beyond.
    Biomolecules, 2021, 01-22, Volume: 11, Issue:2

    Topics: Allosteric Site; Animals; Chromosomes, Human, Pair 22; Citrates; Citric Acid; Cytosol; Diabetes Mell

2021
Consequences of NaCT/SLC13A5/mINDY deficiency: good versus evil, separated only by the blood-brain barrier.
    The Biochemical journal, 2021, 02-12, Volume: 478, Issue:3

    Topics: Animals; Blood-Brain Barrier; Bone and Bones; Citric Acid; Citric Acid Cycle; Dental Enamel; Diabete

2021
Understanding the Central Role of Citrate in the Metabolism of Cancer Cells and Tumors: An Update.
    International journal of molecular sciences, 2021, Jun-19, Volume: 22, Issue:12

    Topics: Animals; Citric Acid; Humans; Neoplasms; Oxidation-Reduction; Tumor Microenvironment; Warburg Effect

2021
[The cancer tumor: a metabolic parasite?].
    Bulletin du cancer, 2013, Volume: 100, Issue:5

    Topics: Amino Acids; Cell Hypoxia; Cell Proliferation; Citric Acid; Glycolysis; Humans; Lipolysis; NADP; Neo

2013
The Warburg effect then and now: from cancer to inflammatory diseases.
    BioEssays : news and reviews in molecular, cellular and developmental biology, 2013, Volume: 35, Issue:11

    Topics: AMP-Activated Protein Kinases; Animals; Carrier Proteins; Cell Line, Tumor; Cell Proliferation; Citr

2013
Citrate--new functions for an old metabolite.
    Biological chemistry, 2014, Volume: 395, Issue:4

    Topics: Acetylation; Animals; Citric Acid; Histones; Humans; Inflammation; Insulin; Insulin Secretion; Mitoc

2014
MALDI mass spectrometric imaging meets "omics": recent advances in the fruitful marriage.
    The Analyst, 2015, Sep-07, Volume: 140, Issue:17

    Topics: Animals; Brain; Calcinosis; Citric Acid; Humans; Metabolomics; Neoplasms; Neuropeptides; Proteomics;

2015
The reduced concentration of citrate in cancer cells: An indicator of cancer aggressiveness and a possible therapeutic target.
    Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2016, Volume: 29

    Topics: Acetyl Coenzyme A; Apoptosis; ATP Citrate (pro-S)-Lyase; Biomarkers, Tumor; Citric Acid; Citric Acid

2016
Viral effects on metabolism: changes in glucose and glutamine utilization during human cytomegalovirus infection.
    Trends in microbiology, 2011, Volume: 19, Issue:7

    Topics: Carbon; Cells, Cultured; Citric Acid; Citric Acid Cycle; Cytomegalovirus; Energy Metabolism; Fatty A

2011
Understanding the central role of citrate in the metabolism of cancer cells.
    Biochimica et biophysica acta, 2012, Volume: 1825, Issue:1

    Topics: Cell Proliferation; Citric Acid; Glycolysis; Humans; Neoplasms

2012
ATP citrate lyase inhibitors as novel cancer therapeutic agents.
    Recent patents on anti-cancer drug discovery, 2012, May-01, Volume: 7, Issue:2

    Topics: Animals; Antineoplastic Agents; ATP Citrate (pro-S)-Lyase; Citric Acid; Drug Design; Enzyme Inhibito

2012
A global view of the biochemical pathways involved in the regulation of the metabolism of cancer cells.
    Biochimica et biophysica acta, 2012, Volume: 1826, Issue:2

    Topics: Adenosine Triphosphate; Animals; Apoptosis; Cell Proliferation; Citric Acid; Citric Acid Cycle; Glyc

2012
In vivo magnetic resonance spectroscopy in cancer.
    Annual review of biomedical engineering, 2005, Volume: 7

    Topics: Animals; Biopsy; Brain; Choline; Citric Acid; Esters; Female; Humans; Hydrogen; Isotopes; Lipids; Ma

2005
'Why do tumour cells glycolyse?': from glycolysis through citrate to lipogenesis.
    Molecular and cellular biochemistry, 2005, Volume: 280, Issue:1-2

    Topics: Aerobiosis; Citric Acid; Glucose; Glycolysis; Lipogenesis; Neoplasms

2005
Tricarboxylic acid cycle dysfunction as a cause of human diseases and tumor formation.
    American journal of physiology. Cell physiology, 2006, Volume: 291, Issue:6

    Topics: Aconitate Hydratase; Citric Acid; Citric Acid Cycle; Fumarate Hydratase; Genes, Tumor Suppressor; Hu

2006
Proposed role for a combination of citric acid and ascorbic acid in the production of dietary iron overload: a fundamental cause of disease.
    Biochemical and molecular medicine, 1995, Volume: 54, Issue:1

    Topics: Aging; Ascorbic Acid; Citrates; Citric Acid; Diet; Disease; Free Radicals; Heart Diseases; Humans; I

1995
[Tumor imaging in nuclear medicine].
    Nihon rinsho. Japanese journal of clinical medicine, 1996, Volume: 54, Issue:5

    Topics: Citric Acid; Gallium Radioisotopes; Gamma Cameras; Humans; Indium Radioisotopes; Neoplasms; Octreoti

1996
[The role of modifying factors in the carcinogenic effect of asbestos and asbestos-containing dusts].
    Eksperimental'naia onkologiia, 1987, Volume: 9, Issue:5

    Topics: Animals; Asbestos; Citrates; Citric Acid; Dust; Humans; Neoplasms; Zirconium

1987

Trials

3 trials available for citric acid, anhydrous and Neoplasms

ArticleYear
CATERPILLAR-study protocol: an assessor-blinded randomised controlled trial comparing taurolidine-citrate-heparin to heparin-only lock solutions for the prevention of central line-associated bloodstream infections in paediatric oncology patients.
    BMJ open, 2023, 03-21, Volume: 13, Issue:3

    Topics: Catheter-Related Infections; Central Venous Catheters; Child; Citrates; Citric Acid; Heparin; Humans

2023
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
    The Egyptian journal of chest diseases and tuberculosis, 2016, Volume: 65, Issue:1

    Topics: A549 Cells; Acetylmuramyl-Alanyl-Isoglutamine; Acinetobacter baumannii; Acute Lung Injury; Adaptor P

2016
Phase I study using desferrioxamine and iron sorbitol citrate in an attempt to modulate the iron status of tumor cells to enhance doxorubicin activity.
    Cancer chemotherapy and pharmacology, 1993, Volume: 31, Issue:5

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Citrates; Citric Acid; Deferoxamine; Do

1993

Other Studies

69 other studies available for citric acid, anhydrous and Neoplasms

ArticleYear
A nomogram prediction of citrate reaction during mononuclear cell collection in solid tumor patients.
    Journal of clinical apheresis, 2023, Volume: 38, Issue:4

    Topics: Citrates; Citric Acid; Humans; Leukocytes, Mononuclear; Neoplasms; Nomograms; Retrospective Studies

2023
The potential for citrate to reinforce epigenetic therapy by promoting apoptosis.
    Trends in endocrinology and metabolism: TEM, 2023, Volume: 34, Issue:10

    Topics: Adenosine Triphosphate; Apoptosis; bcl-X Protein; Citrates; Citric Acid; Epigenesis, Genetic; Humans

2023
Functionalization Of T Lymphocytes With Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles For Magnetically Controlled Immune Therapy.
    International journal of nanomedicine, 2019, Volume: 14

    Topics: Cell Line, Tumor; Citric Acid; Dextrans; Humans; Immunotherapy; Iron; Magnetics; Magnetite Nanoparti

2019
Biotechnological approach to induce human fibroblast apoptosis using superparamagnetic iron oxide nanoparticles.
    Journal of inorganic biochemistry, 2020, Volume: 206

    Topics: Apoptosis; Cancer-Associated Fibroblasts; Cell Death; Cell Line; Cell Survival; Citric Acid; Endocyt

2020
Berberine inhibits cancer cells growth by suppressing fatty acid synthesis and biogenesis of extracellular vesicles.
    Life sciences, 2020, Sep-15, Volume: 257

    Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Antineoplastic Agents; Berberine; Blotting, W

2020
Cytoplasmic Citrate Flux Modulates the Immune Stimulatory NKG2D Ligand MICA in Cancer Cells.
    Frontiers in immunology, 2020, Volume: 11

    Topics: Cell Line, Tumor; Chromatin Assembly and Disassembly; Citric Acid; Cytoplasm; Female; Gene Editing;

2020
Injectable biodegradation-visual self-healing citrate hydrogel with high tissue penetration for microenvironment-responsive degradation and local tumor therapy.
    Biomaterials, 2020, Volume: 261

    Topics: Citric Acid; Doxorubicin; Drug Liberation; Humans; Hydrogels; Neoplasms; Tumor Microenvironment

2020
Fructose-1,6-bisphosphate promotes PI3K and glycolysis in T cells?
    Trends in endocrinology and metabolism: TEM, 2021, Volume: 32, Issue:8

    Topics: Adenosine Triphosphate; Citric Acid; Fructosediphosphates; Glycolysis; Lymphocyte Activation; Mitoch

2021
Size-dependent effect of cystine/citric acid-capped confeito-like gold nanoparticles on cellular uptake and photothermal cancer therapy.
    Colloids and surfaces. B, Biointerfaces, 2018, Jan-01, Volume: 161

    Topics: Cell Line, Tumor; Cell Survival; Citric Acid; Cystine; Endocytosis; Gold; Humans; Metal Nanoparticle

2018
Use of regional citrate anticoagulation for continuous venovenous hemodialysis in critically ill cancer patients with acute kidney injury.
    Journal of critical care, 2018, Volume: 47

    Topics: Acute Kidney Injury; Aged; Anticoagulants; Calcium; Citric Acid; Critical Care; Critical Illness; El

2018
Extracellular Citrate and Cancer Metabolism-Response.
    Cancer research, 2018, 09-01, Volume: 78, Issue:17

    Topics: Citrates; Citric Acid; Humans; Neoplasms

2018
Extracellular Citrate and Cancer Metabolism-Letter.
    Cancer research, 2018, 09-01, Volume: 78, Issue:17

    Topics: Citrates; Citric Acid; Humans; Male; Neoplasms; Prostate

2018
Functionalized nitrogen doped graphene quantum dots and bimetallic Au/Ag core-shell decorated imprinted polymer for electrochemical sensing of anticancerous hydroxyurea.
    Biosensors & bioelectronics, 2019, Feb-15, Volume: 127

    Topics: Biosensing Techniques; Citric Acid; Electrochemical Techniques; Gold; Graphite; Humans; Hydroxyurea;

2019
Engineering multifunctional bioactive citric acid-based nanovectors for intrinsical targeted tumor imaging and specific siRNA gene delivery in vitro/in vivo.
    Biomaterials, 2019, Volume: 199

    Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Cell Line, Tumor; Citric Acid; Diagnostic I

2019
Voltammetric immunosensor for E-cadherin promoter DNA methylation using a Fe
    Mikrochimica acta, 2019, 02-11, Volume: 186, Issue:3

    Topics: Antigens, CD; Biomarkers, Tumor; Cadherins; Cell-Free Nucleic Acids; Citric Acid; DNA Methylation; E

2019
Spatial-fluxomics provides a subcellular-compartmentalized view of reductive glutamine metabolism in cancer cells.
    Nature communications, 2019, 03-22, Volume: 10, Issue:1

    Topics: Animals; Carbon Isotopes; Cell Compartmentation; Cell Hypoxia; Citrate (si)-Synthase; Citric Acid; C

2019
Gluconeogenesis of Cancer Cells Is Disrupted by Citrate.
    Trends in cancer, 2019, Volume: 5, Issue:5

    Topics: Citrates; Citric Acid; Gluconeogenesis; Glycolysis; Humans; Neoplasms

2019
Sensitivity analysis for studying the relation between biochemical reactions and metabolic phenotypes.
    Journal of bioinformatics and computational biology, 2013, Volume: 11, Issue:1

    Topics: Animals; Citric Acid; Citric Acid Cycle; Computer Simulation; Humans; Mitochondria; Models, Biologic

2013
A comment to the article published in the APJCP by Choi and co-workers about the treatment of cancer with citric acid.
    Asian Pacific journal of cancer prevention : APJCP, 2012, Volume: 13, Issue:12

    Topics: Citric Acid; Humans; Neoplasms

2012
Superparamagnetic hollow hybrid nanogels as a potential guidable vehicle system of stimuli-mediated MR imaging and multiple cancer therapeutics.
    Langmuir : the ACS journal of surfaces and colloids, 2013, May-28, Volume: 29, Issue:21

    Topics: Antineoplastic Agents; Cell Proliferation; Citric Acid; Dose-Response Relationship, Drug; Drug Scree

2013
Cationic albumin-conjugated magnetite nanoparticles, novel candidate for hyperthermia cancer therapy.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2013, Volume: 29, Issue:6

    Topics: Albumins; Citric Acid; Hyperthermia, Induced; Magnetite Nanoparticles; Microscopy, Electron, Scannin

2013
Real-time infrared thermography detection of magnetic nanoparticle hyperthermia in a murine model under a non-uniform field configuration.
    International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 2013, Volume: 29, Issue:8

    Topics: Animals; Cell Line, Tumor; Citric Acid; Ferric Compounds; Hyperthermia, Induced; Infrared Rays; Magn

2013
Reductive carboxylation supports redox homeostasis during anchorage-independent growth.
    Nature, 2016, Apr-14, Volume: 532, Issue:7598

    Topics: Cell Adhesion; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Citric Acid; Contact Inhibition;

2016
The effect of superparamagnetic iron oxide nanoparticles surface engineering on relaxivity of magnetoliposome.
    Contrast media & molecular imaging, 2016, Volume: 11, Issue:5

    Topics: Citric Acid; Coated Materials, Biocompatible; Contrast Media; Dextrans; Ferrosoferric Oxide; Humans;

2016
Increased risk of citrate reactions in patients with multiple myeloma during peripheral blood stem cell leukapheresis.
    Journal of clinical apheresis, 2010, Volume: 25, Issue:4

    Topics: Calcium Gluconate; Citric Acid; Hematologic Neoplasms; Humans; Hypocalcemia; Kidney Function Tests;

2010
A radio-frequency coupling network for heating of citrate-coated gold nanoparticles for cancer therapy: design and analysis.
    IEEE transactions on bio-medical engineering, 2011, Volume: 58, Issue:7

    Topics: Cell Death; Cell Line, Tumor; Citric Acid; Electromagnetic Fields; Equipment Design; Gold; Hot Tempe

2011
Selective photothermal efficiency of citrate capped gold nanoparticles for destruction of cancer cells.
    Experimental cell research, 2011, Aug-15, Volume: 317, Issue:14

    Topics: Antibodies, Monoclonal; Citric Acid; Epithelial Cells; Gold; Humans; Laser Therapy; Lasers; Metal Na

2011
Effectiveness of low-dose oral calcium carbonate for the prevention of citrate-related toxicity in peripheral blood stem cell collection.
    Blood transfusion = Trasfusione del sangue, 2012, Volume: 10, Issue:1

    Topics: Administration, Oral; Anticoagulants; Calcium Carbonate; Citric Acid; Female; Hematopoietic Stem Cel

2012
Reductive carboxylation supports growth in tumour cells with defective mitochondria.
    Nature, 2011, Nov-20, Volume: 481, Issue:7381

    Topics: Acetyl Coenzyme A; Animals; Carcinoma, Renal Cell; Cell Hypoxia; Cell Line, Tumor; Citric Acid; Elec

2011
Effectiveness of low-dose oral calcium carbonate for the prevention of citrate-related toxicity in peripheral blood stem cell collection.
    Blood transfusion = Trasfusione del sangue, 2012, Volume: 10, Issue:4

    Topics: Anticoagulants; Calcium Carbonate; Citric Acid; Female; Hematopoietic Stem Cells; Humans; Leukaphere

2012
Analgesic effect of switching from oral opioids to a once-a-day fentanyl citrate transdermal patch in patients with lung cancer.
    The American journal of hospice & palliative care, 2013, Volume: 30, Issue:7

    Topics: Administration, Cutaneous; Analgesics, Opioid; Citric Acid; Fentanyl; Humans; Lung Neoplasms; Neopla

2013
Do mitochondria regulate cellular iron homeostasis through citric acid and haem production? Implications for cancer and other diseases.
    Medical hypotheses, 2003, Volume: 60, Issue:1

    Topics: Blood Platelets; Citric Acid; Heme; Homeostasis; Humans; In Vitro Techniques; Iron; Mitochondria; Mo

2003
Protecting action of citrate on the agent of chicken tumor I (Rous sarcoma virus) during roentgen radiation in vitro.
    Journal of the National Cancer Institute, 1953, Volume: 13, Issue:6

    Topics: Animals; Chickens; Citrates; Citric Acid; In Vitro Techniques; Meat; Neoplasms; Protective Agents; R

1953
Citrate accumulation in slices of transplantable tumors of the rat.
    Cancer research, 1957, Volume: 17, Issue:7

    Topics: Animals; Citrates; Citric Acid; Neoplasm Transplantation; Neoplasms; Rats

1957
[Citric acid blood levels. II. Behavior in various malignant tumors, malignant blood diseases & Hodgkin's disease].
    Zeitschrift fur klinische Medizin, 1957, Volume: 154, Issue:6

    Topics: Citrates; Citric Acid; Hematologic Diseases; Hodgkin Disease; Humans; Lymphatic Diseases; Neoplasms;

1957
[Studies on citric acid synthesis in vitro in normal and malignant tissue].
    Acta biologica et medica Germanica, 1959, Volume: 2, Issue:3

    Topics: Biochemical Phenomena; Citrates; Citric Acid; In Vitro Techniques; Neoplasms

1959
The effect of zirconium citrate on the latent period of Sr89-induced bone cancer in mice.
    Radiation research, 1960, Volume: 13

    Topics: Animals; Bone and Bones; Bone Neoplasms; Citrates; Citric Acid; Mice; Neoplasms; Osteosarcoma; Stron

1960
CITRIC ACID IN METASTASIZING CARCINOMA OF THE PROSTATE GLAND.
    National Cancer Institute monograph, 1963, Volume: 12

    Topics: Carcinoma; Citrates; Citric Acid; Humans; Male; Metabolism; Neoplasm Metastasis; Neoplasms; Prostati

1963
ZIRCONIUM CITRATE REDUCES SR-90 BODY BURDEN.
    Health physics, 1964, Volume: 10

    Topics: Acetazolamide; Animals; Body Burden; Citrates; Citric Acid; Metabolism; Mice; Neoplasms; Neoplasms,

1964
[EFFECT OF PERORALLY ADMINISTERED CITRIC ACID ON BUTTER YELLOW CARCINOGENESIS IN RATS].
    Ernahrungsforschung. Berichte und Mitteilungen, 1964, Volume: 9

    Topics: Carcinogenesis; Carcinogens; Citrates; Citric Acid; Neoplasms; Neoplasms, Experimental; p-Dimethylam

1964
THE ROLE OF CITRIC ACID IN THE PHYSIOLOGY OF THE PROSTATE. 3. LACTATE/CITRATE RATIOS IN BENIGN AND MALIGNANT PROSTATIC HOMOGENATES AS AN INDEX OF PROSTATIC MALIGNANCY.
    The Journal of urology, 1964, Volume: 92

    Topics: Chromatography; Citrates; Citric Acid; Citric Acid Cycle; Humans; Lactates; Lactic Acid; Male; Metab

1964
REDUCTION OF STRONTIUM-90 BONE CANCER BY ZIRCONIUM CITRATE.
    International journal of radiation biology and related studies in physics, chemistry, and medicine, 1964, Volume: 8

    Topics: Acetazolamide; Animals; Bone Neoplasms; Chelating Agents; Citrates; Citric Acid; Metabolism; Mice; N

1964
[The effect of cholin citrate on the leukocyte count during radiotherapy with carcinoma dosage].
    Wiener klinische Wochenschrift, 1954, Nov-19, Volume: 66, Issue:46

    Topics: Choline; Citrates; Citric Acid; Genitalia; Genitalia, Female; Leukocyte Count; Neoplasms

1954
Citric acid in human prostatic secretion and metastasizing cancer of prostate gland.
    British medical journal, 1962, Mar-24, Volume: 1, Issue:5281

    Topics: Adenocarcinoma; Citrates; Citric Acid; Humans; Male; Neoplasms; Prostatic Neoplasms

1962
Pyruvate metabolism. III. Formation of citrate in ascitic nodules from a strain of Walker rat mammary carcinoma 256.
    The Journal of biological chemistry, 1962, Volume: 237

    Topics: Animals; Breast; Citrates; Citric Acid; Neoplasms; Pyruvates; Pyruvic Acid; Rats

1962
A simple and reliable pretreatment protocol facilitates fluorescent in situ hybridisation on tissue microarrays of paraffin wax embedded tumour samples.
    Molecular pathology : MP, 2003, Volume: 56, Issue:5

    Topics: Breast Neoplasms; Buffers; Citric Acid; Clinical Protocols; Female; Humans; In Situ Hybridization; I

2003
Citric acid metabolism in carcinogenesis and its relationships to calcium metabolism.
    Cancer research, 1950, Volume: 10, Issue:10

    Topics: Calcium; Calcium, Dietary; Carcinogenesis; Citric Acid; Humans; Neoplasms

1950
Comparative stability of the agent of chicken tumor I in citrate and phosphate buffers at 37 degrees C.
    Journal of the National Cancer Institute, 1950, Volume: 11, Issue:2

    Topics: Animals; Chickens; Citrates; Citric Acid; Humans; Meat; Neoplasms; Phosphates

1950
Biological activity of the agent of chicken tumor I (Rous) in citrate buffers of various molar concentrations.
    Journal of the National Cancer Institute, 1951, Volume: 11, Issue:5

    Topics: Animals; Chickens; Citrates; Citric Acid; Humans; Meat; Molar; Neoplasms; Sarcoma

1951
Heparin based anticoagulation during peripheral blood stem cell collection may increase the CD34+ cell yield.
    Haematologica, 2004, Volume: 89, Issue:2

    Topics: Adolescent; Anticoagulants; Antigens, CD34; Calcium; Chelating Agents; Child; Child, Preschool; Citr

2004
Citric acid content of normal and tumor tissues in vivo following injection of fluoroacetate.
    Cancer research, 1950, Volume: 10, Issue:6

    Topics: Citric Acid; Fluoroacetates; Humans; Injections; Neoplasms

1950
The citric acid content of tumor tissue and of tumor-bearing rats.
    Cancer research, 1949, Volume: 9, Issue:2

    Topics: Animals; Cells; Citrates; Citric Acid; Neoplasms; Rats

1949
The role of gallium and labeled leukocyte scintigraphy in the AIDS patient.
    The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), 1995, Volume: 39, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Citrates; Citric Acid; Ga

1995
Cancer or inflammation? A Holy Grail for nuclear medicine.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1994, Volume: 35, Issue:10

    Topics: Citrates; Citric Acid; Deoxyglucose; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglu

1994
Do fruit juices stimulate iron absorption and toxicity?
    Human & experimental toxicology, 1995, Volume: 14, Issue:10

    Topics: Aging; Ascorbic Acid; Beverages; Bone Diseases; Citrates; Citric Acid; Diabetes Mellitus; Drug Syner

1995
Metal ion speciation in blood plasma: gallium-67-citrate and MRI contrast agents.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:2

    Topics: Citrates; Citric Acid; Computer Simulation; Contrast Media; Gadolinium; Gallium; Gallium Radioisotop

1996
Hydroxycitrate causes altered pyruvate metabolism by tumorigenic cells.
    Biochemistry and molecular biology international, 1996, Volume: 40, Issue:5

    Topics: Animals; ATP Citrate (pro-S)-Lyase; Carbon Dioxide; Cell Line; Citrates; Citric Acid; Citric Acid Cy

1996
The role of chelators in the catalysis of glutathione-gamma-glutamyl transpeptidase-dependent lipid peroxidation by transition metals.
    Biochemistry and molecular biology international, 1996, Volume: 40, Issue:6

    Topics: Animals; Catalysis; Chelating Agents; Citric Acid; Copper; Ferrous Compounds; gamma-Glutamyltransfer

1996
Shorter turn-around-time and improved patient care in peripheral blood progenitor cell collection procedures.
    Journal of clinical apheresis, 1999, Volume: 14, Issue:1

    Topics: Adult; Ambulatory Care; Anticoagulants; Appointments and Schedules; Blood Banks; Case Management; Ch

1999
Failure of ultrasonic vibration as a means of antigen retrieval in routine diagnostic immunocytochemistry.
    Applied immunohistochemistry & molecular morphology : AIMM, 2000, Volume: 8, Issue:3

    Topics: Antigens; Antigens, CD; Antigens, Surface; Biomarkers, Tumor; Cadherins; CD79 Antigens; Citric Acid;

2000
An improved technique for peripheral blood stem cell collection in small patients.
    Haematologica, 1991, Volume: 76 Suppl 1

    Topics: Adolescent; Blood Volume; Body Weight; Catheterization, Central Venous; Child; Child, Preschool; Cit

1991
Bivariate flow karyotyping of human chromosomes: evaluation of variation in Hoechst 33258 fluorescence, chromomycin A3 fluorescence, and relative chromosomal DNA content.
    Cytometry, 1991, Volume: 12, Issue:6

    Topics: Bisbenzimidazole; Cells, Cultured; Chromomycin A3; Chromosomes, Human; Citrates; Citric Acid; DNA; F

1991
Pediatric solid tumors: evaluation by gallium-67 SPECT studies.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1990, Volume: 31, Issue:2

    Topics: Adolescent; Child; Child, Preschool; Citrates; Citric Acid; Female; Gallium Radioisotopes; Hodgkin D

1990
[Tumor imaging using 99mTc-hexamethylpropyleneamine oxime].
    Kaku igaku. The Japanese journal of nuclear medicine, 1990, Volume: 27, Issue:3

    Topics: Adult; Aged; Citrates; Citric Acid; Female; Gallium Radioisotopes; Humans; Male; Middle Aged; Neopla

1990
[The evaluation of the bone marrow accumulation of Ga-67 citrate].
    Kaku igaku. The Japanese journal of nuclear medicine, 1989, Volume: 26, Issue:11

    Topics: Bone and Bones; Bone Marrow; Citrates; Citric Acid; Female; Gallium Radioisotopes; Hematocrit; Human

1989
[Study on liver uptake changes in serial 67Ga scintigraphy].
    Kaku igaku. The Japanese journal of nuclear medicine, 1989, Volume: 26, Issue:2

    Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Citrates; Citric Acid; Female; Follow-Up Stud

1989
[Tumor imaging in nuclear medicine].
    Nihon rinsho. Japanese journal of clinical medicine, 1989, Volume: 47, Issue:5

    Topics: 3-Iodobenzylguanidine; Amphetamines; Antibodies, Monoclonal; Citrates; Citric Acid; Gallium Radioiso

1989
[Image diagnosis: nuclear medicine].
    Gan no rinsho. Japan journal of cancer clinics, 1988, Volume: 34, Issue:10

    Topics: 3-Iodobenzylguanidine; Citrates; Citric Acid; Female; Humans; Iodine Radioisotopes; Iodobenzenes; Lu

1988
[Use of 111In-citrin in bone marrow scintigraphy].
    Radiologia diagnostica, 1988, Volume: 29, Issue:5

    Topics: Bone Marrow; Citrates; Citric Acid; Humans; Indium Radioisotopes; Neoplasms; Polycythemia Vera; Radi

1988